NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |
| HighVista Strategies LLC | 54,083 | $2,486,196 | 1.15% |
| Nicholas Investment Partners, LP | 268,342 | $12,335,682 | 0.92% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,239,403 | $56,975,356 | 0.74% |
| Soleus Capital Management, L.P. | 154,416 | $7,098,504 | 0.66% |
| Affinity Asset Advisors, LLC | 50,000 | $2,298,500 | 0.65% |
| Avoro Capital Advisors LLC | 812,500 | $37,350,625 | 0.58% |
| Rhenman & Partners Asset Management AB | 86,011 | $3,953,926 | 0.43% |
| Ikarian Capital, LLC | 523 | $2,404,231 | 0.29% |
| EAM Investors, LLC | 27,754 | $1,275,851 | 0.25% |
| Old Well Partners, LLC | 5,800 | $266,626 | 0.23% |
This page lists NUVALENT INC's shareholders in Q3 2023. To view NUVALENT INC's shareholder history, click here.